Ghost Tree Capital as of Dec. 31, 2020
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 42 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Invesco Qqq Tr Unit Ser 1 (QQQ) | 7.0 | $31M | 100k | 313.74 | |
| Syndax Pharmaceuticals (SNDX) | 6.7 | $30M | 1.4M | 22.24 | |
| Trillium Therapeutics Com New | 6.4 | $29M | 2.0M | 14.71 | |
| Rocket Pharmaceuticals (RCKT) | 6.1 | $27M | 500k | 54.84 | |
| Iovance Biotherapeutics (IOVA) | 5.2 | $23M | 500k | 46.40 | |
| Mirati Therapeutics | 4.9 | $22M | 100k | 219.64 | |
| Apellis Pharmaceuticals (APLS) | 4.1 | $19M | 325k | 57.20 | |
| Constellation Pharmceticls I | 4.0 | $18M | 625k | 28.80 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 3.9 | $18M | 105k | 166.78 | |
| Arvinas Ord (ARVN) | 3.9 | $17M | 205k | 84.93 | |
| Mersana Therapeutics (MRSN) | 3.6 | $16M | 600k | 26.61 | |
| Fate Therapeutics (FATE) | 3.3 | $15M | 165k | 90.93 | |
| Immunovant (IMVT) | 3.1 | $14M | 300k | 46.19 | |
| Amicus Therapeutics (FOLD) | 3.1 | $14M | 600k | 23.09 | |
| Tg Therapeutics (TGTX) | 2.9 | $13M | 250k | 52.02 | |
| Travere Therapeutics (TVTX) | 2.9 | $13M | 475k | 27.25 | |
| Cogent Biosciences (COGT) | 2.8 | $12M | 1.1M | 11.23 | |
| Xenon Pharmaceuticals (XENE) | 2.4 | $11M | 700k | 15.38 | |
| Kura Oncology (KURA) | 2.4 | $11M | 325k | 32.66 | |
| Iveric Bio | 2.1 | $9.5M | 1.4M | 6.91 | |
| Surface Oncology | 2.1 | $9.2M | 1.0M | 9.24 | |
| Five Prime Therapeutics | 1.9 | $8.5M | 500k | 17.01 | |
| Sarepta Therapeutics (SRPT) | 1.5 | $6.8M | 40k | 170.50 | |
| BioCryst Pharmaceuticals (BCRX) | 1.5 | $6.7M | 900k | 7.45 | |
| Helix Acquisition Corp Com Cl A | 1.3 | $5.7M | 500k | 11.37 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.3 | $5.7M | 810k | 7.00 | |
| Vistagen Therapeutics Com New | 1.1 | $4.7M | 2.4M | 1.94 | |
| Aldeyra Therapeutics (ALDX) | 1.0 | $4.5M | 650k | 6.86 | |
| Aclaris Therapeutics (ACRS) | 0.9 | $4.2M | 650k | 6.47 | |
| Immunic (IMUX) | 0.9 | $4.1M | 265k | 15.29 | |
| Kalvista Pharmaceuticals (KALV) | 0.8 | $3.8M | 200k | 18.99 | |
| Moderna (MRNA) | 0.8 | $3.7M | 35k | 104.46 | |
| Curis Com New | 0.8 | $3.5M | 425k | 8.19 | |
| Sierra Oncology Com New | 0.7 | $3.2M | 200k | 16.03 | |
| Cti Biopharma | 0.5 | $2.4M | 750k | 3.22 | |
| Millendo Therapeutics | 0.4 | $2.0M | 925k | 2.14 | |
| Amarin Corp Spons Adr New (AMRN) | 0.4 | $2.0M | 400k | 4.89 | |
| Aptevo Therapeutics Com New | 0.4 | $1.8M | 50k | 36.66 | |
| Wave Life Sciences SHS (WVE) | 0.4 | $1.6M | 200k | 7.87 | |
| Otonomy | 0.3 | $1.3M | 200k | 6.47 | |
| Satsuma Pharmaceuticals Ord | 0.2 | $922k | 200k | 4.61 | |
| Biogen Idec (BIIB) | 0.1 | $539k | 2.2k | 245.00 |
